focus -WSS

focus

author：fashion 2025-08-11 07:59:01 - browse：4

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： As Maui death toll rises, number of missing remains unclear

Wikipedia

WSS

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Trump's false claims about Georgia's 2020 election long debunked

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

CRISPR pioneers react to Casgevy, first gene

Why medical students are struggling with mental health

In key trial, Verve's treatment lowers cholesterol levels in patients

hotspot

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

Weight loss drug costs may need more research, senator suggests

Alkermes shareholders re

Childhood cancer progress stalls for Black, Hispanic kids: Report

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Apple is now the first public company to be valued at $3 trillion

Hilary may become 1st tropical storm to make landfall in California in 84 years

Apple is now the first public company to be valued at $3 trillion

Liz Cheney makes 1st public comment since Trump's election interference indictments

knowledge

World's first CRISPR

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Cancer drug shortages' outsize impact on ovarian cancer patients

Eye stem cell transplant could help restore vision in injured people

Patient advocates sound warning on FDA proposal on salt intake

FDA approves first treatment for ultra

focus

Wikipedia

Wikipedia

entertainment